These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19875458)

  • 1. Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation.
    Kim JH; Yoon MS; Chen J
    J Biol Chem; 2009 Dec; 284(51):35425-32. PubMed ID: 19875458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
    Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
    Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids.
    Li H; Lee J; He C; Zou MH; Xie Z
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E197-209. PubMed ID: 24302004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
    Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
    J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes.
    Mashili F; Chibalin AV; Krook A; Zierath JR
    Diabetes; 2013 Feb; 62(2):457-65. PubMed ID: 23043161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospho-Ser727 of STAT3 regulates STAT3 activity by enhancing dephosphorylation of phospho-Tyr705 largely through TC45.
    Wakahara R; Kunimoto H; Tanino K; Kojima H; Inoue A; Shintaku H; Nakajima K
    Genes Cells; 2012 Feb; 17(2):132-45. PubMed ID: 22233524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
    Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
    Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
    Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
    Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
    Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway.
    Kim JH; Kim JE; Liu HY; Cao W; Chen J
    J Biol Chem; 2008 Jan; 283(2):708-15. PubMed ID: 17993646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
    Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
    Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.
    Clementi AH; Gaudy AM; van Rooijen N; Pierce RH; Mooney RA
    Biochim Biophys Acta; 2009 Nov; 1792(11):1062-72. PubMed ID: 19699298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS3 and SOCS6 are required for the risperidone-mediated inhibition of insulin and leptin signaling in neuroblastoma cells.
    Piao L; Park J; Li Y; Shin S; Shin S; Kong G; Shrestha R; Tran Q; Hur GM; Kim JL; Park J
    Int J Mol Med; 2014 May; 33(5):1364-70. PubMed ID: 24626642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.
    Kanatani Y; Usui I; Ishizuka K; Bukhari A; Fujisaka S; Urakaze M; Haruta T; Kishimoto T; Naka T; Kobayashi M
    Diabetes; 2007 Mar; 56(3):795-803. PubMed ID: 17327450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.
    Rezende LF; Santos GJ; Carneiro EM; Boschero AC
    J Biol Chem; 2012 Dec; 287(50):41628-39. PubMed ID: 23038263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of FGF-21 expression promotes hepatic gluconeogenesis and glycogenolysis by regulation of the STAT3-SOCS3 signal.
    Wang C; Dai J; Yang M; Deng G; Xu S; Jia Y; Boden G; Ma ZA; Yang G; Li L
    FEBS J; 2014 May; 281(9):2136-47. PubMed ID: 24593051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells.
    Bluyssen HA; Rastmanesh MM; Tilburgs C; Jie K; Wesseling S; Goumans MJ; Boer P; Joles JA; Braam B
    Am J Physiol Cell Physiol; 2010 Aug; 299(2):C354-62. PubMed ID: 20484656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCBP2 regulates hepatic insulin sensitivity via HIF-1α and STAT3 pathway in HepG2 cells.
    Xia N; Tang Z; Wang C; Xu G; Nie X; Zhang W; Zhao Y; Wang S; Zhu X; Cui S
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):116-22. PubMed ID: 26002461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Egr2 enhances insulin resistance via JAK2/STAT3/SOCS-1 pathway in HepG2 cells treated with palmitate.
    Lu L; Ye X; Yao Q; Lu A; Zhao Z; Ding Y; Meng C; Yu W; Du Y; Cheng J
    Gen Comp Endocrinol; 2018 May; 260():25-31. PubMed ID: 28842216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Key Role of Akt Protein Kinase in Metabolic-Inflammatory Pathways Cross-Talk: TNF-α Down-Regulation and Improving of Insulin Resistance in HepG2 Cell Line.
    Alipourfard I; Bakhtiyari S; Gheysarzadeh A; Di Renzo L; De Lorenzo A; Mikeladze D; Khamoushi A
    Curr Mol Med; 2021; 21(3):257-264. PubMed ID: 32338219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.